Target intelligence / Profile preview

SMARCAL1 antisense RNA 1 (SMARCAL1-AS1)

Target: SMARCAL1-AS1
Molecular classification: Other

Overview

SMARCAL1 antisense RNA 1 (SMARCAL1-AS1) is likely a presumed or predicted non-coding RNA transcribed from the opposite DNA strand of the SMARCAL1 locus. There are no peer-reviewed studies or reputable database entries describing its molecular structure, function, or significance as a protein, therapeutic target, or biomarker. In contrast, the protein-coding SMARCAL1 gene encodes an annealing helicase involved in DNA replication fork maintenance and is linked to Schimke immunoosseous dysplasia. As of September 2025, SMARCAL1-AS1 is not considered a validated or characterized molecular target.

Beyond the preview

Go deeper on SMARCAL1 antisense RNA 1 (SMARCAL1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMARCAL1 antisense RNA 1 (SMARCAL1-AS1).

Explore the full profile